[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354022-105":59,"doc-detail-354022-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ph-responsive-selenium-nanoplatform-for-targeted-drug-release-and-immune-remodeling-in-microbiota-associated-colorectal-cancer-research-open-access","pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer - Research Open Access","","Fusobacterium nucleatum drives colorectal cancer (CRC) initiation, progression, and therapy resistance, yet conventional antibiotics lack specificity and disrupt intestinal homeostasis. A dual bacteria–tumor elimination nanoagent, SeNPs@CBT, integrates antibacterial, antitumor, and tumor-targeting actions. Selenium nanoparticles carry chitosan-4-carboxyphenylboronic acid and release CAPE via pH-sensitive borate ester bonds. In acidic tumor microenvironments, SeNPs@CBT eradicates F. nucleatum, promotes tumor uptake, induces apoptosis, and activates immune responses. In an F. nucleatum–associated CRC mouse model, it suppresses tumor growth, combining bacterial clearance, tumor cell killing, and immune activation. Mechanistically and by transcriptomics, it triggers cell-cycle arrest, mitochondrial dysfunction, and p53 pathway activation, supporting precise treatment of microbiota-related CRC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ph-responsive-selenium-nanoplatform-for-targeted-drug-release-and-immune-remodeling-in-microbiota-associated-colorectal-cancer-research-open-access/354022/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ph-responsive-selenium-nanoplatform-for-targeted-drug-release-and-immune-remodeling-in-microbiota-associated-colorectal-cancer-research-open-access/354022.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is Fusobacterium nucleatum important in colorectal cancer?","Question",{"text":113,"@type":114},"Fusobacterium nucleatum is implicated in CRC initiation, progression, and resistance to therapy. It is enriched in the gut mucosa of CRC patients and is linked to a pro-inflammatory tumor environment and immune evasion.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the design and drug-release mechanism of SeNPs@CBT?",{"text":118,"@type":114},"SeNPs@CBT uses selenium nanoparticles as carriers coated with chitosan-4-carboxyphenylboronic acid and loaded with CAPE. In the acidic tumor microenvironment, pH-sensitive borate ester bonds release CAPE to eliminate F. nucleatum and modulate immune responses.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic effects were observed in the F. nucleatum–associated CRC mouse model?",{"text":122,"@type":114},"SeNPs@CBT markedly suppressed tumor growth and showed synergistic effects across bacterial clearance, tumor cell killing, and immune activation. Mechanistic and transcriptomic results indicate cell-cycle arrest, mitochondrial dysfunction, and p53 signaling pathway activation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354022,1790174359,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Ma etal. Journal of Nanobiotechnology (2026) 24:342 Journal of Nanobiotechnology  \n[https://doi.org/10.1186/s12951-026-04229-0](https://doi.org/10.1186/s12951-026-04229-0)  \nRESEARCH Open Access  \npH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer  \nHaodi Ma1†, Liying Zhang1†, Lulu Wang1,2, Junfeng Liu1, Haoyang Sun1, Shuai Ge1, Baoquan Liu 1,2* and Chunshan Quan1,2*  \nAbstract  \nFusobacterium nucleatum (F. nucleatum) is implicated in colorectal cancer (CRC) initiation, progression, and resistance to therapy, while conventional antibiotics show poor specificity and disrupt intestinal homeostasis. Here, we present a dual bacteria–tumor elimination strategy using a multifunctional nanoagent, SeNPs@CBT, which integrates antibacterial, antitumor, and tumor-targeting functions. Selenium nanoparticles serve as carriers, coated with chitosan-4-carboxyphenylboronic acid and loaded with caffeic acid phenethyl ester (CAPE) via pH-sensitive borate ester bonds. In the acidic tumor microenvironment, SeNPs@CBT release CAPE to eradicate F. nucleatum and modulate immune responses, while the exposed phenylboronic acid groups enhance tumor recognition and uptake, synergistically inducing apoptosis. In an F. nucleatum–associated CRC mouse model, SeNPs@CBT markedly suppressed tumor growth and exhibited potent synergistic effects in bacterial clearance, tumor cell killing, and immune activation. Mechanistic and transcriptomic analyses revealed induction of cell cycle arrest, mitochondrial dysfunction, and activation of the p53 signaling pathway. Together, SeNPs@CBT, based on the triple synergy of bactericidal, tumoricidal, and immune activation, represents a promising nanomedicine platform for the precise treatment of microbiota-related CRC, particularly F. nucleatum–enriched subtypes.  \nKeywords Fusobacterium nucleatum, Colorectal cancer, SeNPs@CBT, Dual bacteria-tumor targeting, Immune modulation  \n†Haodi Ma, Liying Zhang contributed equally to this work.  \n*Correspondence: Baoquan Liu [lbq@dlnu.edu.cn](lbq@dlnu.edu.cn)[ ](lbq@dlnu.edu.cn)Chunshan Quan [mikyeken@dlnu.edu.cn](mikyeken@dlnu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nMa et al. Journal of Nanobiotechnology (2026) 24:342 Page 2 of 23  \nGraphical abstract  \nIntroduction  \nWith a deeper understanding of the mechanisms driving cancer initiation and progression, it has become increasingly clear that cancer is not solely a consequence of uncontrolled proliferation of malignant cells, but rather a complex and dynamic disease influenced by the tumor microenvironment (TME) [1]. TME comprises a dynamic and heterogeneous ecosystem composed of stromal cells, immune components, and, importantly, microorganisms, which collectively regulate tumor initiation, p","cbCairJSU39jqgnh","https://ap.wps.com/l/cbCairJSU39jqgnh","pdf",11522866,23,"English","# Abstract\n## Graphical abstract\n## Introduction","[{\"question\":\"Why is Fusobacterium nucleatum important in colorectal cancer?\",\"answer\":\"Fusobacterium nucleatum is implicated in CRC initiation, progression, and resistance to therapy. It is enriched in the gut mucosa of CRC patients and is linked to a pro-inflammatory tumor environment and immune evasion.\"},{\"question\":\"What is the design and drug-release mechanism of SeNPs@CBT?\",\"answer\":\"SeNPs@CBT uses selenium nanoparticles as carriers coated with chitosan-4-carboxyphenylboronic acid and loaded with CAPE. In the acidic tumor microenvironment, pH-sensitive borate ester bonds release CAPE to eliminate F. nucleatum and modulate immune responses.\"},{\"question\":\"What therapeutic effects were observed in the F. nucleatum–associated CRC mouse model?\",\"answer\":\"SeNPs@CBT markedly suppressed tumor growth and showed synergistic effects across bacterial clearance, tumor cell killing, and immune activation. Mechanistic and transcriptomic results indicate cell-cycle arrest, mitochondrial dysfunction, and p53 signaling pathway activation.\"}]","pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer - Research Open Access | PDF",1790108491,58,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc899fe10a389f8f58db102954e2ce11.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a760c39e5b5a5ac9c2a017816404261.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b70038e0fe56a0a034b0af2d700e00a5.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bc704a14f5b7a2e509cb3e23e935c39.webp",980,1306]